Jing Pang
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 15
- Pharmacology top 5%
- Berberine and alkaloids research 7
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacology top 5%
- Berberine and alkaloids research 7
- Antibiotics Pharmacokinetics and Efficacy 5
- Endocrinology top 10%
-
- Radiomics and Machine Learning in Medical Imaging 7
-
- Bacterial biofilms and quorum sensing 6
-
- Drug Transport and Resistance Mechanisms 6
-
- Sarcoma Diagnosis and Treatment 4
-
- Antimicrobial Resistance in Staphylococcus 4
- Cited by
- Molecular MedicinePharmacology
- Journals
- Angewandte Chemie International Edition (1 paper)PLoS ONE (1 paper)Environmental Pollution (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jing Pang
69 papers receiving 946 citations
Peers
Comparison fields: 5 of 101
- Molecular Medicine 148
- Pharmacology 194
- Pharmacology 92
- Applied Microbiology and Biotechnology 18
- Endocrinology 33
Countries citing papers authored by Jing Pang
This map shows the geographic impact of Jing Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Pang more than expected).
Fields of papers citing papers by Jing Pang
This network shows the impact of papers produced by Jing Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Pang. The network helps show where Jing Pang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 18 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 29 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 65 | |
| 14 | 2020 | 16 | |
| 15 | 2020 | 18 | |
| 16 | 2020 | 59 | |
| 17 | 2019 | 10 | |
| 18 | 2019 | 13 | |
| 19 | 2019 | 30 | |
| 20 | 2018 | 2 |
About Jing Pang
Jing Pang is a scholar working on Molecular Medicine, Pharmacology and Endocrinology, having authored 71 papers that have together received 954 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (15 papers), Berberine and alkaloids research (7 papers), Radiomics and Machine Learning in Medical Imaging (7 papers), Bacterial biofilms and quorum sensing (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Sarcoma Diagnosis and Treatment (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Molecular Medicine (148 citations), Pharmacology (194 citations) and Pharmacology (92 citations). Jing Pang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xuefu You, Xinxin Hu, Congran Li, Xiukun Wang, Xinyi Yang, Yanxiang Wang, Danqing Song, Xi Lü, Jian‐Dong Jiang and Tongying Nie. Their work appears in journals such as Angewandte Chemie International Edition, PLoS ONE and Environmental Pollution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.